BioPorto

Report Publication Announcement • Sep 6, 2019

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

September 6, 2019

Announcement no. 18

Updated Financial calendar for 2019 and Financial calendar for 2020

Date	Description
November 21, 2019	Interim report – for the nine-month period ended September 30th, 2019
February 5, 2020	Deadline for shareholder proposals - Annual General Meeting
February 26, 2020	Annual Report 2019
March 19, 2020	Annual General Meeting
May 7, 2020	Interim Report – for the three-month period ended March 31st, 2020
August 19, 2020	Interim Report – for the six-month period ending June 30th, 2020
November 18, 2020	Interim report – for the nine-month period ended September 30th, 2020

For further information, please contact:

Ole Larsen, CFO

Telephone +45 4529 0000, e-mail investor@bioporto.com

About BioPorto

BioPorto is an in vitro diagnostics company that provides tests and antibodies to clinicians and researchers around the world. We use our antibody and assay expertise to transform novel research tools into clinically actionable biomarkers that can make a difference in patients’ lives. BioPorto is headquartered in Hellerup, Denmark and is listed on the NASDAQ Copenhagen stock exchange [CPH:BIOPOR].

Attachment

• 18 Announcement 2019 09 06